BAMCO Inc
GILD icon

BAMCO Inc’s Gilead Sciences GILD Stock Holding History

BAMCO Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Sell
18,000
-12,000
-40% -$1.58M ﹤0.01% 282
2026
Q1 		$4.18M Buy
30,000
+3,500
+13% +$490K 0.01% 248
2025
Q4 		$3.25M Buy
26,500
+2,500
+10% +$304K 0.01% 270
2025
Q3 		$2.66M Buy
24,000
+5,500
+30% +$625K 0.01% 272
2025
Q2 		$2.05M Buy
18,500
+10,500
+131% +$1.12M 0.01% 273
2025
Q1 		$896K Buy
+8,000
New +$825K ﹤0.01% 293

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BAMCO Inc's GILD Position: Q2 2026 in Review

BAMCO Inc reduced its Gilead Sciences (GILD) stake by 40% in Q2 2026, selling an estimated $1.58M and leaving 18,000 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #282.

BAMCO Inc first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.18M in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BAMCO Inc held 18,000 shares of Gilead Sciences worth $2.27M as of Q2 2026.
  • BAMCO Inc sold 12,000 Gilead Sciences shares in Q2 2026, an estimated $1.58M.
  • Gilead Sciences made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #282 holding.
  • BAMCO Inc first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • BAMCO Inc's Gilead Sciences position peaked at $4.18M in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.